Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include News 9, Luxembourg Times, BioSpace and Nature. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1h ago.
Quick answers
Why is "Cell therapy substantially reduces severe rheumatoid arthritis in first clinical" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Researchers testing ways to reset immune system for patients with autoimmune diseases News 9 · 10h ago
- New hope for people with severe autoimmune diseases Luxembourg Times · 10h ago
- Opinion: CAR Ts will only treat autoimmune diseases if we can scale delivery BioSpace · 10h ago
- CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial Nature · 10h ago
- Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial Medical Xpress · 10h ago
Topics
Related trends
Louisiana Notches a Sickle Cell First
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.